CoChat

FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer

Open access
Karadedou, C T, Gomes, A R, Chen, J, Petkovic, M, Ho, K-K, Zwolinska, A K, Feltes, A, Wong, S Y, Chan, K Y K, Cheung, Y-N, Tsang, J W H, Brosens, J J, Khoo, U-S, Lam, E W-F · 2012 · Oncogene
Cited by 154

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Vascular endothelial growth factor (VEGF) has a central role in breast cancer development and progression, but the mechanisms that control its expression are poorly understood. Breast cancer tissue microarrays revealed an inverse correlation between the Forkhead transcription factor Forkhead box class O (FOXO)3a and VEGF expression. Using the lapatinib-sensitive breast cancer cell lines BT474 and SKBR3 as model systems, we tested the possibility that VEGF expression is negatively regulated by FOXO3a. Lapatinib treatment of BT474 or SKBR3 cells resulted in nuclear translocation and activation of FOXO3a, followed by a reduction in VEGF expression. Transient transfection and inducible expression experiments showed that FOXO3a represses the proximal VEGF promoter, whereas another Forkhead member, FOXM1, induces VEGF expression. Chromatin immunoprecipitation and oligonucleotide pull-down assays showed that both FOXO3a and FOXM1 bind a consensus Forkhead response element (FHRE) in the VEGF promoter. Upon lapatinib stimulation, activated FOXO3a displaces FOXM1 bound to the FHRE before recruiting histone deacetylase 2 (HDAC2) to the promoter, leading to decreased histones H3 and H4 acetylation, and concomitant transcriptional inhibition of VEGF. These results show that FOXO3a-dependent repression of target genes in breast cancer cells, such as VEGF, involves competitive displacement of DNA-bound FOXM1 and active recruitment of transcriptional repressor complexes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2011.368

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Untangling the ErbB signalling network

    Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · cited 2×

    “…may have been shown to function primarily through two pathways the ERK1/2 MAP kinase and PI3K-Akt signalling cascades (Montemurro et al 2007, Yarden and Sliwkowski 2001, Zhang et al 2007), a complete understanding of the mechanism by which HER2/EGFR promotes tumorigenesis remains lacking.”
    Background
  • The FoxO code

    Calnan, D. R., & Brunet, A. (2008) · Oncogene · doi:10.1038/onc.2008.21 · Cited by 1,170 · cited 2×

    “…functions including cell proliferation, apoptosis, differentiation and resistance to oxidative stress and DNA damage (Arden 2008, Burgering 2008, Calnan and Brunet 2008, Fu and Tindall 2008, Gomes et al 2008, Ho et al 2008, Huang and Tindall 2007, Lam et al 2006, Maiese et al 2008, Myatt and…”
    Background
  • FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines

    Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309523200 · Cited by 505

    Self-citation
  • OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins

    Maiese, K., Chong, Z. Z., & Shang, Y. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.03.002 · Cited by 182 · cited 2×

    “…apoptosis, differentiation and resistance to oxidative stress and DNA damage (Arden 2008, Burgering 2008, Calnan and Brunet 2008, Fu and Tindall 2008, Gomes et al 2008, Ho et al 2008, Huang and Tindall 2007, Lam et al 2006, Maiese et al 2008, Myatt and Lam 2007, Reedquist et al 2006).”
    Background

Show all 4 references

Cited by

Metadata

Authors
Karadedou, C. T., Gomes, A. R., Chen, J., Petkovic, M., Ho, K.-K., Zwolinska, A. K., Feltes, A., Wong, S. Y., Chan, K. Y. K., Cheung, Y.-N., Tsang, J. W. H., Brosens, J. J., Khoo, U.-S., & Lam, E. W.-F.
Venue
Oncogene
Published
2011-08-22
Volume
31
Issue
14
Pages
1845-1858
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2067831604
Cited by
154
References
4
FWCI
3.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.